Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
NCT07080476

Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.

Led by Universiteit Antwerpen · Updated on 2025-09-03

128

Participants Needed

4

Research Sites

170 weeks

Total Duration

On this page

Sponsors

U

Universiteit Antwerpen

Lead Sponsor

U

University Ghent

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of the KiTaLymph trial is to investigate whether the application of kinesio tape is effective in women with persistent (\>6 months) breast and/or truncal oedema after treatment for breast cancer. The main objectives are to assess whether kinesio taping: * reduces pain and symptoms, * decreases swelling, * improves quality of life (QoL). This study will compare a control group receiving standard care, decongestive lymphatic therapy (DLT), to an intervention group receiving DLT in combination with kinesio taping, in order to determine whether the addition of kinesio tape yields superior clinical outcomes. Participants will be randomly allocated to one of the two study arms. Both groups will participate in a 4-week intervention phase, consisting of two treatment sessions per week. This will be followed by a 6-month follow-up period to assess the durability of treatment effects and cost-related outcomes. A total of approximately 128 participants will be recruited. Outcome assessments will be conducted at baseline, immediately post-intervention (1 month), and at 3 and 6 months following the end of the intervention. These assessments will include standardised patient-reported outcome measures evaluating symptoms, quality of life, and pain, namely, the Breast Edema Questionnaire (BrEQ), the EORTC-QLQ-BR23, the EQ-5D-5L, and a visual analogue scale (VAS), as well as objective physical measurements of oedema using the LymphScanner (expressed as percentage water content, PWC). In addition to the primary research objective, several sub-studies will be conducted. These will include: (1) a longitudinal analysis of the effects of standard treatment; (2) an evaluation of the responsiveness and clinical utility of the BrEQ; and (3) a cross-sectional analysis of the compression pressure exerted by various compression bras. All sub-studies are methodologically feasible within the projected sample size of the primary objective and aim to provide supplementary insights into the clinical management of breast and truncal oedema.

CONDITIONS

Official Title

Effectiveness of Kinesio Taping in Patients With Chronic Breast and/or Truncal Oedema After Treatment for Breast Cancer.

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female patients previously treated for breast cancer.
  • Persistent breast and/or truncal oedema lasting more than 6 months, established at least six months after completing radiotherapy.
  • Breast Edema Questionnaire (BrEQ) score of 9 or higher.
  • LymphScanner physical water content (PWC) measurements showing at least one of the following: truncal oedema ratio 1.32 or higher; breast oedema ratio 1.28 or higher; local PWC of 52.90%.
  • At least one clinical sign of breast and/or truncal oedema, such as visible swelling compared to the other side, bra imprint on the skin, or peau d'orange appearance on the breast.
Not Eligible

You will not qualify if you...

  • Skin infections or wounds on the breast or trunk that prevent applying kinesio tape.
  • Age under 18 years.
  • Unable to read and understand Dutch.
  • History of mastectomy.
  • Metastatic breast cancer.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 4 locations

1

University of Antwerp

Antwerp, Belgium, 2000

Actively Recruiting

2

Iridium Network

Antwerp, Belgium, 2610

Actively Recruiting

3

Ghent University Hospital

Ghent, Belgium, 9000

Actively Recruiting

4

AZ Groeninge

Kortrijk, Belgium, 8500

Actively Recruiting

Loading map...

Research Team

T

Tessa De Vrieze, Phd pt postdoctoral fellow

CONTACT

N

Nick Gebruers, Associate Professor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here